Cytoplasmic expression of maspin predicts unfavourable prognosis in patients with squamous cell carcinoma of the lung
- 14 February 2016
- journal article
- Published by Wiley in Histopathology
- Vol. 69 (1) , 114-120
Abstract
Aims: Maspin is known to be a tumour suppressor protein, and its prognostic significance in patients with several types of cancer, including lung squamous cell carcinoma (SCC), has been reported. However, its prognostic impact on lung SCC has been controversial. We explored the prognostic value of maspin expression with particular reference to its subcellular localization in patients with lung SCC.Methods and results: Paraffin‐embedded tissue samples from 101 curatively resected patients with lung SCC were analysed immunohistochemically using an antibody for maspin. Maspin positivity was defined as strong expression in only the cytoplasm and observed in 25 patients (24.6%). It correlated significantly with the presence of lymph node metastasis (P = 0.006) and higher pathological stage (P = 0.003). The patients were followed‐up for 2–119 months (median: 50 months), and the maspin‐positive group had shorter disease‐free survival (DFS) and disease‐specific survival (DSS) by log‐rank test (P = 0.002, P = 0.016, respectively). Multivariate analysis revealed that the status of maspin was the only independent prognostic factor for DFS and DSS (P = 0.017, P = 0.047, respectively).Conclusions: Cytoplasmic expression of maspin could be an independent unfavourable prognostic indicator in patients with lung SCC.Keywords
This publication has 26 references indexed in Scilit:
- Role of maspin in cancerClinical and Translational Medicine, 2013
- Cancer statistics, 2013CA: A Cancer Journal for Clinicians, 2013
- Squamous-cell carcinoma of the lungs: Is it really so different?Critical Reviews in Oncology/Hematology, 2012
- Maspin: molecular mechanisms and therapeutic implicationsCancer and Metastasis Reviews, 2012
- Nuclear localization of maspin is essential for its inhibition of tumor growth and metastasisLaboratory Investigation, 2011
- Maspin expression is frequent and correlates with basal markers in triple-negative breast cancerDiagnostic Pathology, 2011
- Nuclear, compared with combined nuclear and cytoplasmic expression of maspin, is linked in lung adenocarcinoma to reduced VEGF‐A levels and in Stage I, improved survivalHistopathology, 2009
- Maspin expression is up-regulated during the progression of endometrioid endometrial carcinomaHistopathology, 2007
- Nuclear and cytoplasmic Maspin expression in primary non-small cell lung cancerJournal of Clinical Pathology, 2006
- Maspin – the most commonly-expressed gene of the 18q21.3 serpin cluster in lung cancer – is strongly expressed in preneoplastic bronchial lesionsOncogene, 2003